Durolane 60 MG/3 ML syringe 3ML
Ended Awarded
- Contract number
- SPE2DB25FDM31
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,038
Award facts
- Contract value 100% obligated
- $34,038.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $34,038 by the Defense Logistics Agency on September 26, 2025. The contract calls for the delivery of Durolane 60 mg/3 mL syringes and is expected to be completed by October 20, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market while leveraging its small business status. The contract is performed at the vendor's Park Ridge, Illinois location.
This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026. This overarching IDC enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support military health facilities nationwide. Durolane, a viscosupplement injection used primarily for osteoarthritis treatment, represents one of the specialized pharmaceutical products available under this extensive supply agreement that serves the Department of Defense's healthcare supply chain requirements.
Quick answers
Who was awarded contract SPE2DB25FDM31?
SPE2DB25FDM31 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FDM31 worth?
The government has obligated $34,038 on SPE2DB25FDM31.
Is contract SPE2DB25FDM31 an order under another contract?
Yes. SPE2DB25FDM31 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM31 competed?
The extent of competition for SPE2DB25FDM31 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award